Explore the endless possibilities of medical imaging applied to oncology with us at ASCO 2024

Join us as we lead the way with our innovative advances at ASCO 2024, taking place in Chicago at the McCormick Center from May 31 to June 4. This year’s theme, “The Art and Science of Oncology Care: From Comfort to Cure,” captures the evolving landscape of oncology, and Quibim is honored to contribute to this transformative journey.

ASCO 2024 is more than just a conference; it serves as a global hub for education, innovation and collaboration in the field of oncology. It is the place where the most innovative strides meet the brightest minds, all driven by a common commitment to improving patient care through cutting-edge technology.

Angel Alberich-Bayarri, Co-founder and CEO of Quibim, comments: “With three abstracts presented and approved, our participation at ASCO 2024 highlights Quibim’s strong commitment to further transform healthcare through innovative imaging solutions. At Quibim we are acutely aware of the real-life impact our products are having, which is why we’re always striving to expand and enhance our products in line with scientific and health industry advancements and we look forward to sharing our latest findings with the ASCO attendees”.

We look forward to seeing you there!

Get ready to meet and book a demo with our team! 

You will find us at booth #34164 in the congress venue at McCormick Place, Chicago.

Book a demo with Quibim’s team for a live demonstration during the days of the event.

Our latest work

Discover how our latest research is setting new standards in oncology, focusing on AI-driven diagnostics and personalized medicine. Our models provide superior risk stratification and survival predictions by leveraging a combination of clinical, molecular and MR radiomic data, and for this congress we have 3 accepted abstracts.

• Prediction of oncogene mutation status in non-small cell lung cancer leveraging radiomics from CT scans: A systematic review and meta-analysis with a special focus on artificial-intelligence-based methods – Almudena Fuster-Matanzo, Alfonso Picó Peris | Online presentation

• Unleashing deep features and radiomics to enhance best overall response prediction to immunotherapy in advanced non-small cell lung cancer  – Gemma Urbanos | Online presentation

• Overall survival prediction and risk stratification in patients with neuroblastoma through machine learning in the large multi-institutional PRIMAGE cohort – Jose Lozano Montoya | Poster presented by our Vice President of AI, Dr. Ana Jimenez.

QP-Insights^®: a robust imaging platform enabling precision medicine. Discover boundless opportunities. 

This tool is a comprehensive web-based cloud platform that centrally manages, stores and quantitatively analyzes multi-omics data and is interoperable with other registries. Our integrated platform and products can be used to augment their analytical capabilities and extract new predictive models and biomarkers by linking image data with processed electronic health record (EHR) data.

We have a strong track record in the life sciences industry, proven to handle data management needs in more than 125 centers worldwide (Phase 1-4 environments) by more than 1,000 clinicians and researchers. This solution is developed with the highest care and precision, reflecting our passion for excellence in healthcare.

Download our QP-Insights^® brochure

Quibim at ASCO 2024: From Comfort to Cure 

We’re looking forward to seeing you!